Yu L - Search Results

1

The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.

Yao L, Cao LH, Qiu LX, Yu L. Yao L, et al. Among authors: yu l. Breast Cancer Res Treat. 2010 Sep;123(2):577-80. doi: 10.1007/s10549-010-0784-4. Epub 2010 Feb 12. Breast Cancer Res Treat. 2010. PMID: 20151320

2

Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.

Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L. Peng B, et al. Among authors: yu l. Mutagenesis. 2010 Jan;25(1):41-8. doi: 10.1093/mutage/gep041. Epub 2009 Oct 20. Mutagenesis. 2010. PMID: 19843588

3

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.

Yao L, Fang F, Wu Q, Yang Z, Zhong Y, Yu L. Yao L, et al. Among authors: yu l. Breast Cancer Res Treat. 2010 Jul;122(1):221-7. doi: 10.1007/s10549-009-0679-4. Epub 2009 Dec 15. Breast Cancer Res Treat. 2010. PMID: 20013047

4

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.

Yao L, Fang F, Wu Q, Zhong Y, Yu L. Yao L, et al. Among authors: yu l. Breast Cancer Res Treat. 2010 Jul;122(1):237-42. doi: 10.1007/s10549-009-0689-2. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033481

5

TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.

Fang F, Yao L, Yu XJ, Yu L, Wu Q, Yu L. Fang F, et al. Among authors: yu l, yu xj. Breast Cancer Res Treat. 2010 Jul;122(1):267-71. doi: 10.1007/s10549-009-0698-1. Epub 2009 Dec 25. Breast Cancer Res Treat. 2010. PMID: 20035378

6

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.

Yao L, Yu X, Yu L. Yao L, et al. Among authors: yu l, yu x. Breast Cancer Res Treat. 2010 Jul;122(2):503-7. doi: 10.1007/s10549-009-0717-2. Epub 2010 Jan 6. Breast Cancer Res Treat. 2010. PMID: 20052535 Review.

7

The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.

Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Yu L. Yao L, et al. Among authors: yu l, yu xj. Breast Cancer Res Treat. 2010 Aug;122(3):879-82. doi: 10.1007/s10549-010-0742-1. Epub 2010 Jan 20. Breast Cancer Res Treat. 2010. PMID: 20087647

8

The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects.

Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Hu XC, Yu L. Yao L, et al. Among authors: yu l, yu xj. Breast Cancer Res Treat. 2010 Aug;123(1):227-31. doi: 10.1007/s10549-010-0754-x. Epub 2010 Feb 2. Breast Cancer Res Treat. 2010. PMID: 20127278

9

The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.

Yao L, Fang F, Zhong Y, Yu L. Yao L, et al. Among authors: yu l. Breast Cancer Res Treat. 2010 Nov;124(1):223-7. doi: 10.1007/s10549-010-0800-8. Epub 2010 Mar 5. Breast Cancer Res Treat. 2010. PMID: 20204503

10

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.

Peng B, Cao L, Ma X, Wang W, Wang D, Yu L. Peng B, et al. Among authors: yu l. Mutagenesis. 2010 Jul;25(4):371-9. doi: 10.1093/mutage/geq015. Epub 2010 Apr 1. Mutagenesis. 2010. PMID: 20360147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,251 results

Search Page

Filters